Navigation Links
Warner Chilcott Reports Operating Results for the Quarter Ended March 31, 2009 and Updates 2009 Full Year Guidance
Date:5/11/2009

r average selling prices. The increase in filled prescriptions of DORYX, primarily relating to DORYX 150 mg, was due to increased promotional efforts behind DORYX 150 mg, including our recently launched customer loyalty card program. The increase in filled prescriptions of 22.6% is not fully reflective of the impact on net sales as the value per DORYX 150 mg prescription is greater than the value of a filled prescription of the other strengths. Net sales of TACLONEX decreased $0.3 million, or 0.8%, to $36.6 million in the quarter ended March 31, 2009, compared to $36.9 million in the prior year quarter. As filled prescriptions on a per-gram basis were essentially flat, net sales of TACLONEX decreased primarily due to higher sales-related deductions during the quarter ended March 31, 2009 and a contraction in pipeline inventories relative to the prior year period. This decrease was partially offset by higher average selling prices in the quarter ended March 31, 2009 as compared to the prior year quarter. Net sales of DOVONEX decreased by $5.2 million, or 15.6%, in the quarter ended March 31, 2009, compared with the prior year quarter. The decline was due primarily to a decrease in filled prescriptions of 24.6% and higher sales-related deductions, offset partially by higher selling prices and an expansion of pipeline inventories relative to the prior year quarter.

Net sales of our hormone therapy products increased $0.6 million, or 1.2%, in the quarter ended March 31, 2009, compared with the prior year quarter. Net sales of ESTRACE CREAM increased $4.0 million, or 20.7%, in the quarter ended March 31, 2009 compared to the prior year quarter. The increase was primarily due to an increase in filled prescriptions of 15.4% and higher average selling prices, offset in part, by a contraction of pipeline inventories relative to the prior year quarter. Net sales of FEMHRT decreased $3.3 million, or 20.8%, in the quarter ended March 31, 2009 compared to the p
'/>"/>

SOURCE Warner Chilcott Limited
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17

Related medicine news :

1. Warner Chilcott Proposes Redomestication From Bermuda to Ireland
2. Warner Chilcott to Present at the Bank of America and Merrill Lynch 2009 Health Care Conference
3. Warner Chilcott Files New Lawsuit for Infringement of DORYX(R) Patent
4. HBO, Warner Bros. Employee Initiatives and the Alzheimers Association, California Southland Chapter Present a Free, Public, Advance Screening of THE ALZHEIMERS PROJECT: Caregivers
5. Warner Chilcott Announces Earnings Release Date and Conference Call For First Quarter 2009 Financial Results
6. Warner Chilcott Files New Lawsuit for Infringement of DORYX(R) Patent
7. Warner Chilcott Announces Receipt of FDA Response to Citizen Petition
8. Warner Chilcott Announces Receipt of Paragraph IV Certification Notice
9. Virginia Faith Leaders Call on Senators Webb & Warner to Support Legislation to Protect Kids from Tobacco
10. Virginia Faith Leaders Call on Sens. Webb & Warner to Support Legislation to Protect Kids From Tobacco
11. Warner Chilcott Reports Operating Results for the Quarter and Year Ended December 31, 2008
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/21/2015)... Dallas, Texas (PRWEB) April 21, 2015 ... Review, H1 2015” provides comparative analysis on ... strengthens R&D pipelines by identifying new targets ... products. Complete report with TOC is available ... report also reviews key players involved in ...
(Date:4/21/2015)... Angelo’s FabriClean has recently announced that ... clients that avail the area rug cleaning services. Area ... with hi-tech equipments, making use of the quick drying ... natural, high pressure steam extraction to clean even the ... area rugs made with delicate fabric. , “Good ...
(Date:4/21/2015)... Calif. (PRWEB) April 21, 2015 Information is ... , Kevin Ryan, MD, FACP, empowers patients and their families ... Tumor is the Rumor and Cancer is the Answer" and ... authoritative and informative language to guide patients from diagnosis through ... make patients active participants in their treatment, at home and ...
(Date:4/21/2015)... & New York, NY (PRWEB) April 21, 2015 ... global provider of advanced delivery technologies and development ... today announced the launch of ADVASEPT™ Lock, a ... and efficient delivery of injectable medications. Easily opened, ... a safe, convenient and functional container closure with ...
(Date:4/21/2015)... (PRWEB) April 21, 2015 Lyft ... Edition 2 for otolaryngologists, bringing the most advanced ... healthcare community. Otolaryngologists can now experience the ... a trusted source in the industry, Lyft, which ... with leading EHRs. , “Lyft is very excited ...
Breaking Medicine News(10 mins):Health News:Sinusitis Therapeutic Development and Pipeline Market Review H1 2015 Available at RnRMarketResearch.com 2Health News:Sinusitis Therapeutic Development and Pipeline Market Review H1 2015 Available at RnRMarketResearch.com 3Health News:Angelo’s FabriClean Now Offers Area Rug Cleaning in South Surrey with Complimentary Pick-Up and Delivery 2Health News:Authoritative guide and new accompanying therapeutic web portal bridge information gaps in cancer treatment 2Health News:Catalent Announces the Expansion of its Advanced, Aseptic, Glass-Free Injectable Platform with New ADVASEPT™ Lock Delivery Technology 2Health News:Lyft Expands Its Offerings to Include Dragon® Medical Practice Edition 2 for Otolaryngologists. 2
... today announced,the release and first shipment of their marine-grade ... chair to oil and,gas platform operators in the Gulf ... platforms will enable the safe and timely evacuation of ... the dual-track MOV in response to the offshore,industry demands ...
... TAMPA, Fla., May 13 A complete review ... of a multi-disciplinary and,collaborative approach to weight loss, ... Clinics(R). The use of several proven,weight management strategies ... offer the greatest likelihood of success., NBC,s ...
... Performance during Sports or Play, CARLSBAD, Calif., May ... and retailer of custom-fitted arch supports and,natural sponge rubber ... of arch supports designed specifically for children ages 6 ... "SportFlex," are now,currently available at participating Good Feet Stores ...
... Israel, May 13 Lumenis Inc., a ... and radiofrequency,devices for surgical, aesthetic, and ophthalmic ... Laser Enucleation of the Prostate (HoLEP),preceptor program ... are interested in learning and performing HoLEP. ...
... 2008 Johnson & Johnson today announced that Professor ... Ravinder N. Maini, FRCP, FMedSci, FRS of the Kennedy ... the recipients of the 2008 Dr. Paul Janssen Award ... world-renowned scientists. , The award salutes the most ...
... Denmark, May 12, Warner Chilcott and LEO ... and Drug Administration (FDA) has approved the,New ... 0.005% and,betamethasone dipropionate 0.064%) Topical Suspension. LEO ... the FDA in July 2007. Taclonex Scalp(R) ...
Cached Medicine News:Health News:Research Converging in Favor of New Approach to U.S. Weight Problem 2Health News:Good Feet Announces New Arch Support Product Line for Children Ages 6 and Older 2Health News:Lumenis Launches HoLEP Preceptor Program at American Urology Association 2008 Annual Meeting 2Health News:Lumenis Launches HoLEP Preceptor Program at American Urology Association 2008 Annual Meeting 3Health News:Marc Feldmann and Sir Ravinder Maini win Dr. Paul Janssen Award for Biomedical Research 2Health News:Marc Feldmann and Sir Ravinder Maini win Dr. Paul Janssen Award for Biomedical Research 3Health News:FDA Approves Taclonex Scalp(R) - Once Daily Therapy for Treatment of Moderate to Severe Scalp Psoriasis 2Health News:FDA Approves Taclonex Scalp(R) - Once Daily Therapy for Treatment of Moderate to Severe Scalp Psoriasis 3Health News:FDA Approves Taclonex Scalp(R) - Once Daily Therapy for Treatment of Moderate to Severe Scalp Psoriasis 4
(Date:4/21/2015)... BROOK, N.Y. , April 21, 2015 /PRNewswire/ ... in health insurance marketplace integration and business operation, ... Entity (WBE) with the Centers of Medicare & ... establish an enrollment channel with access to the ... enrollment of eligible consumers into qualified health insurance ...
(Date:4/21/2015)... 2015 Seattle Children,s announced today that 20 ... trial using genetically reprogrammed T cells to treat relapsed ... by highly sensitive tests designed to detect minute amounts ... complete remission included children with very high tumor burdens ... as infants. "These results are extremely encouraging," ...
(Date:4/21/2015)... April 21, 2015 Legal cannabis ... to grow at a rapid pace over the next ... provide technology services for indoor/outdoor cultivators and new cannabis ... Surna Inc. (OTC: SRNA), Totally Hemp Crazy Inc. (OTC: ... (OTC: BVAP), 22 nd Century Group, Inc. (NYSE: ...
Breaking Medicine Technology:Softheon Confirms Web Broker Entity (WBE) Status with the Centers of Medicare & Medicaid Services (CMS) 2Seattle Children's Pediatric Leukemia Adoptive Therapy (PLAT-02) Clinical Trial Boasts 91% Complete Remission Rate in Children with Relapsed Leukemia 2Seattle Children's Pediatric Leukemia Adoptive Therapy (PLAT-02) Clinical Trial Boasts 91% Complete Remission Rate in Children with Relapsed Leukemia 3New Technology, Innovative Products & State-of-the-Art Equipment in the Legal Cannabidiol Industries Continue to Provide Growing Revenue Opportunities 2New Technology, Innovative Products & State-of-the-Art Equipment in the Legal Cannabidiol Industries Continue to Provide Growing Revenue Opportunities 3New Technology, Innovative Products & State-of-the-Art Equipment in the Legal Cannabidiol Industries Continue to Provide Growing Revenue Opportunities 4New Technology, Innovative Products & State-of-the-Art Equipment in the Legal Cannabidiol Industries Continue to Provide Growing Revenue Opportunities 5New Technology, Innovative Products & State-of-the-Art Equipment in the Legal Cannabidiol Industries Continue to Provide Growing Revenue Opportunities 6New Technology, Innovative Products & State-of-the-Art Equipment in the Legal Cannabidiol Industries Continue to Provide Growing Revenue Opportunities 7
... , , PRINCETON, N.J., Nov. 30 ... will present at the Piper Jaffray 21st Annual Health Care Conference ... may access a live webcast of the presentation at www.covance.com ... please log on 10 minutes early. , Covance, with headquarters in ...
... The Special Committee of Independent Directors of Patheon Inc. ("Patheon" ... its affiliate, JLL Patheon Holdings, LLC (collectively, "JLL"), today announced ... agreement in respect of the pending legal actions between the ... that: , until March 2011, the Board will consist ...
Cached Medicine Technology:Patheon and JLL Partners Announce Litigation Settlement 2Patheon and JLL Partners Announce Litigation Settlement 3
... optical collection, inspired by the ... Mademoiselle's heart, from the interlinked ... effect. Combining the purity of ... Strass and other light reflections, ...
... and sunwear, inspired by modern ... style, with long lasting wearability. ... collection include sophistication, elegance and ... clean modern shapes, classic styling ...
... frame mounting technology has redefined rimless collections ... taper at the end of each frame ... of the bushing that mounts within the ... a secure fit is created that far ...
... The new GUCCI DONNA eyewear collection ... house,incorporating, with a vintage yet contemporary feel, ... leader., The new GUCCI UOMO optical and ... is,presented in classic lines with cutting-edge design ...
Medicine Products: